MENU
IMDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Insight Molecular Diagnostics (IMDX) Ownership - Who owns Insight Molecular Diagnostics?
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes... Show more
Industry: #Medical Specialties
Profile
Industry
Medical Specialties
Address
15 Cushing
Phone
+1 949 409-7600
Employees
76
Web
https://www.oncocyte.com
Details
Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
24.2M
P/E Ratio
4.56
Total Cash
14.22M
Projected Growth
N/A
Total Debt
3.07M
Revenue
1.46M
Risk (Beta)
1.61
Dividend Yield
N/A
Total Cash/Share
1.72
Total Debt/Equity
N/A
Revenue/Share
0.21 USD as % of share price
Fundamentals
IMDX
Capitalization
24.2M
P/E Ratio
4.56
Risk (Beta)
1.61
Dividend Yield
N/A
Total Cash
14.2M
Total Cash/Share
1.72
Total Debt
3.07M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.21%
Revenue
1.46M
ROE
N/A
Book Value
37.6M
P/B Ratio
0.66
Cash Flow
N/A
Earnings
-9.66
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
310M
Current Ratio
2.11
Current Revenue Per Employee
5644.74
Dividends Per Share - Security
N/A
EBITDA
-10.44M
Float
N/A
Float - Current
N/A
Gross Income Margin
57.81
Revenue To Assets
-48.33
Shares Held By Institutions
12M
Shares Outstanding - Current
8.26M
Total Liabilities
44M
Total Volume MTD
N/A
Value
N/A
Gain YTD
20.168
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of ovel, non-invasive, liquid biopsy diagnostics for the early detection of cancer
Industry MedicalSpecialties
Profile
Fundamentals
Details
Industry
Medical Specialties
Address
15 Cushing
Phone
+1 949 409-7600
Employees
76
Web
https://www.oncocyte.com